Testing effectiveness (Phase 2)Study completedNCT00458913
What this trial is testing
Bortezomib and Cisplatin as First-Line Therapy in Treating Patients With Malignant Mesothelioma
Who this might be right for
Malignant Mesothelioma
European Organisation for Research and Treatment of Cancer - EORTC 82